Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
13.83
-0.67 (-4.62%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Attovia Therapeutics Revenue
Attovia Therapeutics had revenue of $450.00K in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $1.80M. In the year 2025, Attovia Therapeutics had annual revenue of $1.35M. That makes Attovia Therapeutics the 42,610th largest company in the world by revenue and 5,832nd in the United States.
Revenue (ttm)
$1.80M
Revenue Growth
n/a
P/S Ratio
350.75
Revenue / Employee
$40,909
Employees
44
Market Cap
631.36M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.35M | - | - |
| Dec 31, 2024 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ATTO News
- 26 days ago - Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026 - GlobeNewsWire
- 5 weeks ago - Attovia Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - Attovia Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Attovia Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Attovia reports Q2 EPS ($4.88), consensus ($4.61) - TheFly
- 7 weeks ago - Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 7 weeks ago - Attovia Therapeutics Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Attovia Therapeutics Earnings release: Q2 2026 - Filings